CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|171|5|726-735

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.171, Iss.5, 2015-12, pp. : 726-735

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Role of Serum Lactate Dehydrogenase Beyond Initial Diagnosis: A Retrospective Analysis of Patients with Diffuse Large B Cell Lymphoma

By  

Acta Haematologica, Vol. 130, Iss. 4, 2013-08 ,pp. : 305-311

Karger

Access to resources Recommend Favorite

Pretreatment Serum Level of 15-kDa Granulysin Might Have a Prognostic Value in Patients with Diffuse Large B Cell Lymphoma

By  

Acta Haematologica, Vol. 126, Iss. 2, 2011-05 ,pp. : 79-86

Karger

Access to resources Recommend Favorite

Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B‐cell lymphoma in the rituximab era

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 5, 2015-12 ,pp. : 776-783

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inflammatory Biomarkers in Diffuse Large B-Cell Lymphoma: Time for Extending the Established Prognosis Scores?

By  

Acta Haematologica, Vol. 137, Iss. 2, 2017-01 ,pp. : 73-75

Karger

Access to resources Recommend Favorite

The Prognostic Impact of Absolute Lymphocyte and Monocyte Counts at Diagnosis of Diffuse Large B-Cell Lymphoma in the Rituximab Era

By  

Acta Haematologica, Vol. 130, Iss. 4, 2013-07 ,pp. : 242-246

Karger

Access to resources Recommend Favorite